Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Immucor Launches Enhanced Customer Education Platform

Published: Wednesday, January 02, 2013
Last Updated: Wednesday, January 02, 2013
Bookmark and Share
Immucor LEARN is an effective, innovative solution which enables increased access to training and expert insights.

Immucor, Inc., has announced the launch of its innovative e-learning customer education platform, Lab Education And Resource Network (LEARN).

LEARN enables blood bank professionals to gain knowledge about their field and connect with peers through interactive case studies and online educational materials.

The LEARN platform is an important tool for those seeking to increase their blood bank knowledge and skills and it also allows them to earn P.A.C.E. credits.

"As a long-standing leader in blood bank diagnostics, Immucor is answering our customers' need for learning opportunities that increase flexibility and minimize costs and travel time. We turned to Knowledge Anywhere, a leader in education in the diagnostics market, to improve and expand upon our current customer education processes," said Bill Childs, Immucor's Director of North American Marketing.

"We previewed the LEARN System with our customers at the 2012 AABB Annual Meeting and received an overwhelming, positive response," Mr. Childs continues.

Mr. Childs continued, "We are happy to announce that LEARN is now generally available at our website. LEARN is unique in that it provides blood bank continuing education opportunities on-line at no charge for Immucor customers."

Through LEARN, Immucor will provide online courses and case studies from industry experts. The case studies allow blood bankers to comment, participate and learn from their peers' experiences.

LEARN can be accessed 24/7 via Immucor's Customer Center at www.immucor.com and provides blood bankers with the knowledge to advance the practice of transfusion medicine and improve patient outcomes.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

FDA Approve Immucor MDx Test
PreciseType™ HEA test becomes the first-ever FDA-approved diagnostic for molecular typing of donor and recipient red blood cells for blood transfusions.
Friday, May 23, 2014
Scientific News
The Mending Tissue - Cellular Instructions for Tissue Repair
NUS-led collaborative study identifies universal mechanism that explains how tissue shape regulates physiological processes such as wound healing and embryo development.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
iPS Cells Discover Drug Target for Muscle Disease
Researchers have designed a model that reprograms fibroblasts to the early stages of their differentiation into intact muscle cells in a step towards a therapeutic for Duchenne muscular dystrophy.
Engineered Hot Fat Implants Reduce Weight Gain
Scientists at UC Berkeley have developed a novel way to engineer the growth and expansion of energy-burning “good” fat, and then found that this fat helped reduce weight gain and lower blood glucose levels in mice.
Transplanted Stem Cells Can Benefit Retinal Disease Sufferers
Tests on animal models show that MSCs secrete growth factors that suppress causes of diabetic retinopathy and macular degeneration.
MRI Scanners Can Steer Therapeutics to Specific Target Sites
Scientists from the University of Sheffield have discovered MRI scanners, normally used to produce images, can steer cell-based, tumour busting therapies to specific target sites in the body.
Team Finds Early Inflammatory Response Paralyzes T Cells
Findings could have enormous implications for immunotherapy, autoimmune disorders, transplants and other aspects of immunity.
Early Detection of Lung Cancer
The University of Manchester has signed a collaboration agreement with Abcodia to perform proteomics studies on a cohort of non-small cell lung cancer cases from the UKCTOCS biobank, with the aim of discovering new blood-based biomarkers for earlier detection of the disease.
Researchers Identify Drug Candidate for Skin, Hair Regeneration
Formerly undiscovered role of protein may lead to the development of new medications that stimulate hair and skin regeneration in trauma or burn victims.
Basis for New Treatment Options for a Fatal Leukemia in Children Revealed
Detailed molecular analyses allow new insights into the function of tumour cells and options for new treatments.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!